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Abstract 
Myostatin is a negative regulator of skeletal muscle growth. Knock-out mice 
have been shown to have a 200% increase in skeletal muscle mass primarily to 
myofiber hyperplasia and to a lesser extent, hypertrophy. Numerous mutations 
within myostatin have been identified which are responsible for the double-muscled 
phenotype in cattle. However, the molecular mechanisms whereby myostatin 
inhibits skeletal muscle mass are not fully understood. The goal of this research 
was to identify genes that are differentially expressed in double-muscled versus 
normal-muscled embryos in order to identify potential candidate genes that may be 
regulated by myostatin activated pathways. Suppressive subtractive hybridization 
was performed in order to identify genes that had increased expression in either 
double-muscled or normal-muscled bovine embryos. Crossbred Belgian Blue dams 
and sires were selected to minimize genetic variation at loci other than myostatin. 
Embryos were collected at 31 to 33 days of gestation, which is 2 to 4 days after the 
initial expression of myostatin. Thirty-one clones were identified that were potentially 
differentially expressed. Macroarray analysis of the original RNA samples confirmed 
that 20 of these clones were differentially expressed in the original cDNA libraries. 
Several of these genes have biological functions that correspond very well with 
myostatin's role in skeletal muscle development. However, whole embryos were 
utilized for the suppressive subtractive hybridization. In order to determine if they 
were expressed in skeletal muscle, expression levels in myoblasts and myotubes 
were analyzed. Only a few of the genes were expressed in myoblasts or myotubes. 
The genes that were not expressed may have been important during specification of 
ix 
the somite, or myostatin may play a systemic role and the genes are actually 
expressed elsewhere in the embryo. This research added potential insight about the 
molecular mechanisms whereby myostatin inhibits skeletal muscle mass. 
Furthermore, several of these genes map to quantitative trait loci known to interact 
with the presence or absence of myostatin. Physical mapping was completed on 
genes that were in QTL regions and single nucleotide polymorphisms were identified 
for genes in these regions. These will be used to discover if these genes contain 
myostatin interacting alleles. 
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Chapter 1. General Introduction 
Introduction 
In recent years, improved feed efficiency and increased skeletal muscle mass 
in order to increase profits has become progressively more important in the beef 
cattle industry. Selective breeding and dietary formulation have greatly improved 
dressing percent and feed efficiency. This evolution of the industry has allowed 
producers to improve margins by essentially decreasing their bottom line cost of 
production. Although this development has provided great benefit, today's narrow 
production margins enhance the need for improved efficiency and increased muscle 
mass through genetic manipulation. 
Economic benefits of increased muscle mass are clearly a priority in meat 
animal production. However, the understanding of molecular mechanisms that could 
be used to increase muscle mass could play a very different and important role in 
human health. Several examples of atrophy in human muscle already exist. For 
example, muscle mass decreases due to aging, microgravity environment, AIDS 
muscle wasting syndrome, and disuse. Better understanding of molecular 
mechanisms involved in the regulation of skeletal muscle mass may be critical for 
preventing atrophy, as well as for increasing muscle mass. 
Myostatin, a negative regulator of skeletal muscle mass, is the subject of the 
research presented in this thesis. In cattle, mutations have been identified in 
myostatin that results in the double-muscled phenotype, in which muscle mass is 
increased by 20 to 30%. In addition, the loss of functional myostatin protein results 
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in decreased fat depth, improved feed efficiency, yield grade. However, double 
muscled cattle are not universally accepted in the U.S. commercial beef industry as 
these cattle have decreased ability to cope with environmental stress, and cows 
have increased dystocia and decreased fertility. Therefore, an understanding of 
myostatin is necessary to bypass these negative effects and utilize the increased 
muscle mass that can be attained. 
In human health, increased knowledge of the molecular mechanism of 
myostatin may be beneficial as its expression is regulated during atrophy. 
Pharmacological approaches could be utilized to block myostatin or genes that are 
in myostatin's pathways in order to decrease the negative regulation of skeletal 
muscle mass. 
In this study, we sought to identify potential candidate genes that may be 
regulated in myostatin pathways. Differentially expressed genes in double-muscle 
versus normal-muscled cattle were identified. Further analysis was completed on 
genes that appeared to be at quantitative trait loci that interact with the presence of 
absence of myostatin. 
This study may provide valuable information about the regulation of skeletal 
muscle mass by myostatin. This information could be helpful in improving the 
efficiency of production systems, as well as potentially having a role in the 
improvement of human health. 
Thesis Organization 
This thesis is written in alternative format. In the first chapter, a general 
introduction and review of current literature are presented. The second chapter is in 
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manuscript form for submission to Animal Genetics. The third and fourth chapters 
present more of the author's research. In the final chapter, implications of this 
research are discussed as well as ideas for future research. 
Literature Review 
Double-Muscling 
Research began on double-muscling in the early 1800's. Culley (1807) and 
Youatt ( 1834) recognized that some breeds of cattle had a large increase in muscle 
mass as compared to the other breeds of cattle. The increase in muscle mass in 
double-muscled cattle occurs pren.atally, and double-muscled cattle have 20 to 30% 
more muscle mass from fetal development through maturity. The increase occurs in 
all locomotory skeletal muscles, and this increase is caused primarily by skeletal 
muscle hyperplasia, which is an increase in the number of myofibers in skeletal 
muscle. This was determined by cross-section analysis of the muscle. A small 
amount of hypertrophy, or an increase in the diameter of the myofibers, was also 
found to occur (Swatland and Kieffer 1974). 
In addition to the increased skeletal muscle mass, changes also occur in 
other quantitative traits. Double-muscled cattle have an increased ability to convert 
feed into lean muscle. These cattle have decreased backfat thickness with a 50% 
reduction in total lipid content in the body. In contrast, meat tenderness was not 
significantly changed, which suggests that meat quality is not negatively correlated 
· with the double-muscled phenotype (Hanset et al. 1986). However, double-muscled 
Jcattle have not been universally accepted by the commercial beef industry, as 
4 
double-muscled cows have problems with dystocia and fertility. In addition, double-
muscled cattle have reduced ability to cope with environmental stress (Hanset 
1991): 
In order to determine if the double-m.uscled phenotype followed Mendelian 
segregation, back-cross analysis has been completed. Double-muscled Belgian 
Blue bulls and normal-muscled Friesian cows were crossed to produce the F1 
generation (C.harlier et al. 1995). Results from this /Study, suggested that double-
muscling is the result of a single gene effect, and indeed followed Mendelian 
segregation. Microsatellite analysis was completed to determine the chromosomal 
location of the locus responsible for the double-muscled phenotype, which was 
named the muscle hypertrophy (mh) locus (Charlier et al. 1995). Subsequently, 
myostatin has been identified as the gene at the mh locus responsible for regulating 
skeletal muscle mass, and mutations in myostatin result in double. muscling 
(McPherron et al. 1997, Grobet et al. 1997, McPherron and Lee 1997, and 
Kambadur et al. 1997). 
Myostatin and the TGF-P Superfamily 
Myostatin, originally named Growth and Differentiation Factor 8 (GDF8), was 
identified as a novel TGF-13 superfamily member. It was cloned by degenerate PCR 
against a region conserved among several known TGF-13 superfamily members 
(McPherron et al. 1997). 
Members of the TGF-13 superfamily have all been shown to have important 
roles in growth. Members of this family of growth factors include transforming 
growth factor 13 (TGF-13). bone morphogenic proteins (BMP), growth and 
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differentiation factors (GDF), activins, inhibins, as well as many others (reviewed by 
Heldin et al. 1997, Padgett and Patterson 2001 ). 
One of the functions of the TGF-13 superfamily members is to inhibit cell 
proliferation in many types of cells including carcinoma cells, fibroblasts, and 
myoblasts (Zhang and Jacobberger 1996, McPherron et al. 1997, Bergman et al. 
1997). In order to better understand the biological function of several TGF-13 
superfamily members, knock-out mice have been studied (Reviewed by Chang et al. 
2001 ). In many cases, inactivation of TGF-8 superfamily members results in 
embryonic lethality (Solloway and Robertson 1999, Chagraoui et al. 2001 ). For 
example, the inactivation of TGF-131 resulted in embryonic lethality due to defective 
hematopoiesis (Dickson et al. 1995). In contrast, the myostatin knock-out mouse 
lives through adulthood and has a significant increase in skeletal muscle mass, 
which suggest that myostatin inhibits skeletal muscle growth (McPherron et al. 
1997). 
Myostatin has all the hallmarks of the TGF-13 superfamily. Family members 
have cysteine residues that are required for the formation of disulfide bridges and 
folding of the protein (Reviewed by Venkataraman et al. 1995). The TGF-13 
superfamily members also have a group of hydrophobic amino acids at the N-
terminus of the propeptide which are required for proteolytic processing of the 
protein from its inactive, precursor form to its active form. 
The TGF-13 superfamily member proteins are ligands, which bind to a cognate 
receptor, which in turn activates signal transduction. The receptor is usually a 
Ser/Thr receptor kinase. When the ligand binds, formation of a complex consisting 
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of type I and II receptor kinases occurs. The type II receptor autophosphorylates 
and then phosphorylates the type I receptor. Next, they phosphorylate the SSXS or 
RRXR motif of the R smads. This, in turn forms a complex with the Smads in order 
to enter the cell nucleus, where they regulate transcription (Roberts 1999). 
The family members also are known to be dimers and are active in a homo-
or hetero-dimeric form (Reviewed by Gumienny and Padgett 2002). Myostatin is 
suggested to function as a homodimer. In addition, myostatin appears to signal 
through the activin type II receptor (Lee and McPherron 2001), and subsequently, 
through SMAD 3 (Langley et al. 2002). 
Myostatin Gene and Identified Polymorphisms 
Myostatin has 3 exons and 2 introns and is transcribed as a 2.9 kb mRNA. 
The first exon is 506 bp, the second 374 bp, and the third is variable in length. The 
third exon's length can be 1701, 1812; or 1887 bp due to alternative splicing. 
(McPherron et al. 1997, Jeanplong et al. 2001). 
In order to determine the biological function of this new TGF-J3 superfamily 
member, myostatin null mice were generated. These myostatin knockout mice had 
the entire third exon of myostatin, which encodes for the majority of the biologically 
active portion of myostatin, replaced with a neomycin cassette. The knockout 
mouse was found to have a dramatic 200% increase in skeletal muscle mass, with 
approximately a 30% increase in body size. In contrast, other organs did not 
increase in size (McPherron et al. 1997). Similarly, bone size did not change, except 
for at the insertion end (Hamrick et al. 2000, Hamrick et al. 2002). From this 
research, it appears that myostatin is a negative regulator of skeletal muscle growth. 
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The increase in muscle mass in the myostatin null mice was due to myofiber 
hyperplasia (Mc Pherron et al. 1997). This phenotype was very similar to the 
increase in muscle mass observed in double-muscled cattle. Since GDF8 knock-out 
mice and double-muscled cattle had a similar phenotype, it was proposed that 
mutations in myostatin may be responsible for the double-muscled phenotype. 
Subsequently, numerous mutations have been identified in myostatin (Grobet et al. 
1997). 
Piedmontese cattle, which traditionally express the double-muscled 
phenotype, have a single base pair mutation in the third exon of myostatin. This 
guanine to adenine mutation at position 938 results in an amino acid change from 
cysteine to tyrosine at amino acid 313 (Mc Pherron and Lee 1997). This cysteine 
residue is the third of nine cysteine residues that are required for myostatin activity 
(Berry et al. 2002). The nine cysteines are highly conserved in all members of the 
TGF-(3 superfamily. From analysis of the processing and secretion of Piedmontese 
myostatin, it is likely that the cysteine residue is required for proper folding of 
myostatin, as it is involved in the cysteine knot formation (Berry et al. 2002). 
Double-muscled Begian Blue cattle have an 11 base pair deletion in 
myostatin. This mutation in exon 3 referred to as nt821 (del11), leads to a 
premature stop codon (Kambadur et al. 1997, McPherron and Lee 1997, and Grobet 
et al. 1997). Thus, myostatin is formed as a truncated protein and is not functional. 
Furthermore, a number of mutations have been identified in other cattle 
breeds (Grobet et al. 1997). In this study, six mutations were identified in myostatin. 
All of these mutations either result in a premature stop codon or disruption of a 
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cysteine residue that is required for myostatin protein to function. These mutations 
included the two mutations previously identified in Belgian Blue and Piedmontese 
cattle. In addition, a single base pair change was identified that occurs at position 
61 O in myostatin in Charlois and Limousine cattle. This change is from a cysteine to 
a tyrosine at the fifth of nine cysteine residues in myostatin. Another mutation, in 
Maine-Anjou cattle, results from a 7 base pair deletion of nucleotides at positions 
419 to 425 from the start codon in exon 2, and an insertion of 1 O base pairs at the 
point of the deletion that leads to a premature stop codon. Futhermore, there is a 
single base pair change of guanine to thymine at position 676, leading to a 
premature stop codon in myostatin in Maine-Anjou cattle. Finally, in Marchigiana, 
there is a single base pair change of guanine to thymine at nucleotide position 87 4, 
which results in a premature stop codon. 
Of the mutations identified in cattle, one has been studied in mice. The 
Piedmontese mutation was shown to induce myofiber hyperplasia similar to that 
seen in double-muscled cattle (Nishi et al. 2002). Additionally, a unique mutation 
exists in the propeptide region of murine myostatin. This mutation leads to a mouse 
with a hypermuscular phenotype, called compact (Cmpt). Compact mice have a 6 
and 9 % increase in body size in females and males, respectively (Szabo et al. 
1998, Varga et al. 1997). 
Mutations in myostatin result in the double-muscled phenotype. Therefore, 
myostatin was identified as a candidate gene for the mh locus (Smith et al. 1997). 
Myostatin was positioned on Chromosome 2, which is the same chromosome as the 
position of the mh locus, with the use of fluorescent in situ hybridization (FISH) 
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(Smith et al. 1997, Charlier et al. 1995). Linkage analysis was used to map 
myostatin to the mh locus (Smith et al. 1997). Furthermore, comparative mapping of 
human and bovine has provided a high resolution map for determining the location 
of genes in humans and cattle, with myostatin positioned at the mh locus (Pirottin et 
al. 1999). 
Regulation of Protein and Secretion 
In plantaris and soleus extracts, latent myostatin migrates as a 35 kDa and 
37 kDA protein, respectively. Intact, unprocessed myostatin migrates as a 52 kDA 
protein under reducing conditions. However, under non-reducing conditions, 
myostatin migrates as a 11 O kDA protein. The proteolytically processed, active, 
form of myostatin migrates as a 15 kDA protein under reducing conditions. In 
contrast, myostatin migrates as a 26 kDA protein under non-reducing conditions 
(McPherron and Lee 1997, Taylor et al. 2001). From this information, myostatin 
appears to be functional as a dimer. 
The secretion of myostatin from the cell appears to be regulated by titin cap, 
or telethionin (T-cap). T-cap protein physically interacts with fully processed 
myostatin. In cell culture, overexpression of T-cap resulted in increased myoblast 
proliferation as a result of decreased myostatin secretion (Nicholas et al. 2002). 
Myostatin mRNA in expression is increased in double-muscled animals as 
compared to wild-type animals. This is contrary to what is expected, as you would 
expect increased myostatin to block proliferation and differentiation, decreasing 
muscle mass instead of having double-muscled"animals. However, myostatin 
protein is not functional in double-muscled animals. Therefore, it has been 
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suggested that the loss of myostatin protein may lead to a loss of feed back 
regulation. This, in turn, may result in elevated myostatin mRNA expression 
· (Oldham et al. 2001 ). 
Regulation of Myostatin Gene 
Promoter 
The myostatin promoter has recently been characterized. It contains 
glucocortocoid response elements, a TAT A box, a CCAA T box, MyoD binding sites, 
MEF2 binding sites, a PPARy binding site, a NF-kB binding site, and regions 
homologous to the POU homeodomain proteins (Ma et al. 2001, Spiller et al. 2002). 
This large number of putative DNA binding sites suggests that myostatin's 
expression is tightly regulated. 
Prenatal Expression of Myostatin 
Myostatin is first expressed in the myotomal compartment of the somite of the 
developing embryo. In cattle, mRNA expression was first detected at very low levels 
by RT-PCR analysis at 18 days of gestation (Kambadur et al. 1997). Myostatin 
expression was much easier to detect at 31 days of gestation, suggesting a dramatic 
increase in mRNA expression levels (Kambadur et al. 1999). In mice, myostatin 
mRNA expression was first detected at 9.5 days post coitus (d.p.c.) in the myotomal 
region of the most anterior somites. However, by 10 d.p.c. myostatin was expressed 
in a majority of the somites (McPherron et al. 1997). 
Postnatal Expression of Myostatin in Skeletal Muscle 
In postnatal skeletal muscle, myostatin mRNA expression does not appear to 
change with age (Reardon et al. 2001, Welle et al. 2002, Marcell et al. 2001 ). 
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However, myostatin protein level does increase with age (Marcell et al. 2001, Siebert 
et al. 2001). 
In C2C12 cells, myostatin expression is higher in differentiating myotubes 
than in proliferating myoblasts (Artaza et al. 2002). Furthermore, myostatinappears 
to be expressed in a fiber type specific manner. Myostatin mRNA can be detected 
by Northern Blot analysis in the fast gastrocnemius and plantaris muscles, which are 
composed of type II x/d and type II b fibers. However, myostatin mRNA expression 
was undetectable in the slow soleus muscle, which is composed of type I and type 
Ila fibers (Carlson et al. 1999). In addition, myostatin mRNA abundance was found 
to correlate with the percentage of myosin heavy chain isoform (MyHC) llb 
expression levels. Myostatin mRNA concentration is higher in cells that express 
MyHC II, as compared to cells that express MyHC I (Artaza et al. 2002, Carlson et 
al. 1999). 
Expression of Myostatin in Other Tissues 
Myostatin is also expressed in a few tissues other than skeletal muscle. 
However, myostatin mRNA and protein are present at much lower concentrations. 
Myostatin mRNA is expressed in the secretory lobules of the mammary gland of 
lactating females, suggesting a regulatory role in lactating mammary gland growth 
(Ji et al. 1998). In addition, myostatin expression was detected in both 
cardiomyocytes and Purkinje fibers of the heart (Sharma et al. 1999). Myostatin 
mRNA expression is upregulated in cardiomyocytes after cardiac infarct in the 
regions bordering the infarct area (Sharma et al. 1999). In addition, very low levels 
of myostatin mRNA expression were detected in the brain of several fish species 
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(Roberts and Goetz 2001). These findings suggest a role for myostatin in non-
skeletal muscle tissues. 
Myostatin mRNA expression level decreases during the differentiation of 
preadipocytes into adipocytes (Kim et al. 2001 ). In myostatin knockout mice, 
adipogenesis is decreased significantly. In addition, the circulating amounts of leptin 
are decreased (Lin et al. 2002). Moreover, by crossing myostatin null mice to obese 
. (Lepobtob) mice, or agouti yellow lethal (AY) mice, fat cell number and size was 
decreased by 40% and 25%, respectively (McPherron and Lee 2002). Lepob/ob and 
AY mice that were myostatin null had decreased fat deposition, as well as increased 
muscle mass. Therefore, myostatin may be involved in adipogenesis, or changes in 
adipocytes may occur due the increase in muscle mass which requires increased 
energy consumption, and therefore, less adipose storage. Due to confounding 
effects with these studies, myostatin's role in adipogenesis cannot be fully 
elucidated. 
Myostatin Expression in Atrophy and Hypertrophy 
Models of Atrophy 
Myostatin expression is regulated during regeneration of skeletal muscle 
following injury, as well as during atrophy and hypertrophy. The changes in 
myostatin mRNA expression in two models of skeletal muscle regeneration have 
been reported. One model involved an incision of the muscle, while the other model 
evaluated regeneration after thermal injury (Kirk et al. 2000, Lang et al. 2001 ). In 
these two studies, myostatin mRNA expression was very low immediately after injury 
and decreased even further during regeneration. This suggests that myostatin plays 
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an important role in regulation of skeletal muscle mass in adult tissue, as well as 
during embryonic development. 
In the case of skeletal muscle atrophy, several studies have been completed. 
During muscle unloading in mice, skeletal muscle mass decreased by 17% to 42% 
after seven days of unloading (Carlson et al. 1999). In contrast, myostatin mRNA 
expression increased by 67% after one day of unloading, but returned to normal by 
seven days of unloading. In a similar study, rats were subjected to hindlimb 
unloading for 1 O days (Wehling et al. 2000). In the unloaded muscles, which 
included the plantaris muscle, the concentration of myostatin mRNA was increased 
by 17-fold, with a significant 37% increase in myostatin protein concentration in the · 
plantaris muscle. Plantaris muscle mass decreased by 16% as a result of 
unloading. These results suggest that myostatin may be involved in skeletal muscle 
mass postnatally. 
Submission of an animal to a microgravity environment is another model of 
atrophy. During spaceflight, muscle mass decreased and myostatin mRNA 
expression increased 1 .9- to 5-fold in the gastrocnemius, tibialis anterior, 
guadriceps, and the biceps femoris (Lalani et al. 2000). Bedrest, also a model of 
atrophy, results in changes in myostatin expression similar to that observed during 
spaceflight. In order to increase the atrophy of the muscle, triiodothyronine (T3), an 
inducer of atrophy was administered to participants in the study during bed rest. 
Plasma myostatin levels were measured and were significantly increased due to bed 
rest, with a greater increased in participants that were subjected to bed rest with the 
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administration of T3. Muscle mass decreased significantly by approximately 1 % 
(Zachwieja et al. 1999). 
In HIV infected men, skeletal muscle atrophy results in a 10% decrease in 
body mass. In contrast, myostatin protein concentration increased by 25% 
(Gonzalez-Cadavid et al. 1998). In addition, atrophy due to disuse of the skeletal 
muscle was studied in patients undergoing hip replacement surgery. Muscle 
samples from these individuals were analyzed before and after surgery to determine 
the degree of atrophy. During atrophy, myostatin mRNA expression increased 
significantly by -30-fold (Reardon et al. 2001 ). 
Model of Hypertrophy 
Overloading of the plantaris muscle by removal of the soleus and 
gastrocnemius muscles resulted in decreased myostatin.protein expression 
(Sakuma et al. 2000). In this study, there was a 56% increase in the weight of the 
plantaris muscle after 1 day of overloading. The increase in muscle mass due to 
hypertrophy was 76% after 4 weeks. During overloading, overall total muscle 
protein concentration in the muscle increased. 
Effect of Myostatin on Proliferation and Differentiation 
Proliferation 
Myostatin inhibits myoblast proliferation in C2C12 cells, an immortalized cell 
line, as well as in bovine primary satellite cells. In the presence of myostatin, 
myoblasts are unable to transition from G1 to the S phase of the cell cycle, which 
causes the myoblasts to the exit the cell cycle and enter into a quiescent like state 
(Thomas et al. 2000, Taylor et al. 2001, Rios et al. 2001 ). 
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Differentiation 
Myostatin expression increases during myoblast terminal differentiation. This 
resulted in myostatin in turn inhibiting terminal differentiation (Rios et al. 2002, 
Artaza et al. 2002). In contrast, the hydroxamate-based inhibitor of 
metalloproteases (HIMP) was shown to induce myoblast fusion by inducing 
differe.ntiation. Metalloproteases are known to activate growth factors and cytokines. 
Thus, it has been suggested that HIMP inhibits a metalloprotease that activates 
myostatin, thereby, repressing myostatin activity and resulting in increased skeletal 
muscle mass (Huet et al. 2001). 
Protein Synthesis 
It has been suggested that myostatin inhibits myotube protein synthesis 
(Taylor et al. 2001). Protein synthesis decreased by 50% in myoblasts and 75% in 
myotubes in the presence of 6µg/ml of recombinant myostatin protein. Myostatin 
protein appears to inhibit cell proliferation, as well as differentiation, which would 
decrease the total protein synthesis. However, in this study, myostatin was added to 
cells during proliferation, and proliferation and differentiation were decreased. The 
decrease in protein synthesis may have been due to a decreased number of 
myoblasts present, therefore fewer cells present and less total protein. 
Transgenic Mice and Myostatin 
Researchers have generated transgenic mice that over-express dominant 
negative myostatin (dnMS) in skeletal muscle (Zhu et al. 2000). Skeletal muscle 
specific expression was accomplished by having dnMS expression under the control 
of the muscle creatine kinase promoter; In these transgenic mice, muscle mass 
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increased by 20 - 35%. However, the increase in skeletal muscle mass was due to 
skeletal muscle hypertrophy, unlike the changes in skeletal muscle mass in double-
muscled cattle and myostatin null mice, which are due to myofiber hyperplasia. 
A transgenic mouse line has over-expressesion of the pro-domain of 
myostatin, which is the region of myostatin from the N-terminus to the proteolytic 
processing site RSRR. This overexpression results in 1 O - 46% increase in skeletal 
muscle mass, which is due to myofiber hypertrophy. The range is due to variable 
expression of the pro-domain, where increased muscle mass is associated with 
higher expression of the pro-domain (Yang et al. 2001). 
Two other lines of transgenic mice have also been studied. Mice with a 
dominant negative form of the activin type II receptor were found to have 125% 
increase skeletal muscle mass, which was due to myofiber hypertrophy and 
hyperplasia. While, mice over-expressing follistatin have increased muscle mass 
similar to that of the myostatin knock-out (Lee and McPherron 2001 ). However, the 
increase in muscle size due to hypertrophy and hyperplasia ranged from 194 -
327%. This increase is much larger than that in myostatin null animals. 
Embryogenesis 
During embryonic development, somites form from the lateral plate 
mesoderm and subsequently differentiate into myoblasts and eventually skeletal 
muscle. The somites lie along the primitive streak during early embryonic 
development. Somite specification results in myoblasts, which are the precursor cell 
for skeletal muscle determination. These myoblasts make up the myotome and the 
dermamyotome portions of the somite. The location of the somite within the body 
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determines the final fate of its myoblasts. Myoblasts formed in the regions farthest 
from the neural tube are involved in the formation of the limb skeletal muscle (Gilbert 
2000). After the mononucleated myoblasts exit the cell cycle, the myoblasts align 
and fuse, leading to the formation of multinucleated myotubes. These myotubes 
then develop into the muscle fiber. (Gilbert 2000) 
In cattle, differentiation of early myoblasts into primary myotubes begins at 39 
days of gestation at a crown rump length of 20 cm in normal-muscled cattle, and is 
completed by 180 days of gestation. Secondary myotubes form after 180 days of 
gestation, at an approximate crown rump length of 50. Fiber number increases until 
240 days of gestation (Robelin et al. 1991, Gagniere et al. 1999, Russell and 
Oteruelo 1981 ). 
In the mouse, the primitive streak stage embryo is at 7.5 days post coitus 
(d.p.c.). At this time, the embryo possesses about 6 to 8 pairs of somites. By 10 
d.p.c., the mouse has around 35 pairs of somites. By 13.5 d.p.c., the embryo has 
about 55 pairs of somites. At this stage, primary myotube development begins. At 
17.5 d.p.c., secondary myotube formation begins (Ontell et al. 1984). In mice, 
myostatin is first expressed at 10.5 days in the majority of the somites which 
corresponds to the time when myostatin is first expressed in cattle (Mc Pherron et al. 
1997). 
Myostatin and Interacting Quantitative Trait Loci 
Myostatin has been shown to account for a large amount of the genetic 
variation in muscle mass and fat deposition in double-muscled cattle. However, the 
remaining variation cannot be explained by myostatin. There are potentially genes 
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that interact with the presence or absence of myostatin, and quantitative trait loci 
· (QTL) have been identified that interact with alternative alleles of myostatin (Casas 
et al. 2000, Casas et al. 2001). 
In order to identify these QTL, two families of cattle from a Belgian Blue or a 
Piedmontese background were studied. Cattle were bred to be 1A Belgian Blue or 1A 
Piedmontese. The Belgian Blue cattle were crossed with MARC Ill cattle (1A 
Hereford, 1A Angus, 1A Pinzgauer, 1A Red Poll). Crossbred Piedmontese-Angus and 
Piemontese-Hereford dams were backcrossed to Piedmontese sires (Casas et al. 
1998). 
QTL for myostatin interacting alleles were identified for a number of growth 
and carcass traits. These included birth weight, weaning weight, yearling weight, fat 
depth, marbling, tenderness, longissimus muscle area, kidney pelvic heart fat, retail 
product yield grade, and USDA yield grade (Casas et al. 1998). 
Several chromosomes have regions with suggestive QTL for possible 
myostatin interacting alleles (Casas et al. 1998, Casas et al. 1999). Chromosome 5 
has putative QTL for fat depth, retail product yield grade, and Warner Bratzler shear 
force (WBS) at day 14 postmortem. A suggestive interaction between alternative 
myostatin alleles and the genetic background on chromosome 5 was identified. 
(Casas et al. 2000) Similar interactions·appear to exist on chromosome 8 and 14 
for fat depth (Casas et al. 2000), and chromosome 4 for WBS at 3 days postmortem 
(Casas et al. 2000, Casas et al. 2001 ). 
QTL that may contain genes that interact with myostatin have been identified 
for several quantitative traits including WBS at 14 days postmortem, yield grade, and 
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fat depth. Genes whose expression differs between double-muscled and normal-
muscled animals may make good interacting allele candidates. The identification of 
these genes, which are differentially expressed due to changes in myostatin could 
lead to additional information about the change occurring in the traits of interest. 
Myostatin mRNA and protein concentrations change during atrophy and 
hypertrophy. This suggests that myostatin has a postnatal role in the regulation of 
muscle mass in addition to its prenatal role. In addition, changes that occur in the 
presence or absence of myostatin cannot be explained by myostatin alone. 
Therefore, it would appear that myostatin is upstream of several downstream 
targets, and differences in the expression of these genes may result in the changes 
in quantitative traits that occur in double-muscled and normal-muscled animals. 
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Myostatin, a member of the transforming growth fact<?r-13 (TGF-13) superfamily, 
is a negative regulator of skeletal muscle groWth. Knock-out mice have been shown 
to have a 200% increase in skeletal muscle mass primarily to myofiber hyperplasia 
and to a lesser extent, hypertrophy. Numerous mutations within myostatin have 
been identified which are responsible for the double-muscled phenotype in cattle. 
However, the molecular mechanisms whereby myostatin inhibits skeletal muscle 
mass are not fully understood. The goal of this research was to identify genes that 
are differentially expressed in double-muscled versus normal-muscled embryos in 
order to identify potential candidate genes that may be regulated by myostatin-
activated pathways. To identify these genes, suppressive subtractive hybridization 
was performed, with both forward and reverse subtractions being completed in order 
to identify genes that had increased expression in either double-muscled or normal-
muscled bovine embryos. Crossbred Belgian Blue dams and sires were selected to 
minimize genetic variation at loci other than myostatin. Embryos were collected at 
31 to 33 days of gestation, which is 2 to 4 days after the initial expression of 
myostatin in the somite. From the suppressive subtractive hybridization, 31 clones 
were. identified that were potentially differentially expressed. Macroarray analysis of 
the original RNA samples confirmed that 20 of these clones were differentially 
expressed. Several of these genes have biological functions that correspond very 
well with myostatin's role in skeletal muscle development. Furthermore, several of 
these genes map to quantitative trait loci known to interact with the presence or 
absence of myostatin. 
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Introduction 
Culley (1807} first described the double-muscled phenotype in cattle. In 
double-muscled cattle, the increase in skeletal muscle mass, which occurs 
prenatally, is primarily due to hyperplasia, or an increase in muscle fiber number, 
coupled with a small amount of hypertrophy, or increased myofiber diameter 
(Swatland and Kieffer, 1974). Belgain Blue and Piedmontese double-muscled cattle 
have an -30% increase in skeletal muscle mass, in addition to increased birth 
weight, rib eye area, feed efficiency, and improved retail product yield grade (Hanset 
et al. 1986). However, double-muscled cattle have problems with dystocia, 
decreased female fertility, and lower stress tolerance (Han set et al. 1991). Due to 
these management problems, double-muscled cattle are not preferred for use in 
commercial beef production in the United States. Furthermore1 the extremely low 
level of intramuscular fat deposition has relegated meat from double-muscle cattle to 
niche markets. 
In 1997, myostatin was identified as a gene with homology to conserved 
regions within TGF-13 superfamily members (McPherron et al. 1997). Myostatin must 
be proteolytically processed to be active, and nine cysteine residues are necessary 
for proper folding and homodimerization of myostatin (Berry et al. 2002). To 
determine the biological function of this new TGFf3 superfamily member, knock-out 
mice were produced. The myostatin null mice have an -200% increase in skeletal 
muscle mass, which is due to myofiber hyperplasia (McPherron et al. 1997). Since 
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the identification of myostatin, researchers have been trying to identify the molecular 
mechanisms whereby myostatin regulates skeletal muscle growth. 
Myostatin is first expressed at very low levels in the 18 day bovine embryo. 
However, expression was easily detected by 29 days of gestation (Kambadur et al. 
1997). Myostatin expression is primarily restricted to the myotomal compartment of 
the somite, which will give rise to myoblasts (Gagniere et al. 1999). Later in 
embryonic development, myostatin is expressed in all skeletal muscles and its 
expression is seen throughout development (Lee and McPherron 1999). 
Myostatin has been reported to decrease myoblast proliferation (Thomas et 
al. 2000, Taylor et al. 2001, Rios et al. 2001 ). Myoblasts appear to exit the cell cycle 
and enter into a quiescent state. In addition, myostatin inhibits terminal 
differentiation of myoblasts (Rios et al. 2002, Artaza et al. 2002). Furthermore, 
myostatin represses myoD mRNA expression, which is important for myogenic 
commitment (Oldham et al. 2002). Myostatin appears to have several downstream 
targets, whose role may be to.regulate the skeletal myoblast cell cycle progression 
and terminal differentiation. 
In order to begin to further elucidate the molecular mechanism and pathways 
through which myostatin functions, suppressive subtractive hybridization was 
completed to identify genes that are differentially expressed in double-muscled 
versus normal-muscled embryos. Genes that are differentially expressed in normat-
muscled versus double-muscled cattle may be downstream targets of myostatin. 
Furthermore, they should make excellent candidate genes for interaction with the 
presence and absence of myostatin null alleles. 
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Materials and Methods 
Embyro Collection. Heterozygous myostatin null crossbred dams and sires 
were naturally mated to generate wild-type and myostatin null embryos. Crossbred 
Belgian Blue dams and sires were selected to minimize genetic variation at loci other 
than myostatin. Dams were slaughtered, and embryos were collected between 31 
and 33 days of gestation, which is 2 to 4 days after the initial expression of myostatin 
in the developing embryo (Kambadur et al. 1997). 
RNA processing. RNA was extracted using the RNeasy midi kit (Qiagen) 
according to the manufacturer's protocol. Briefly, tissue (-150 mg) from two normal-
(32 days old) and two double-muscled embryos (31 and 32 days old) was 
homogenized in the presence of RL T buffer (Qiagen) with a Polytron (Brinkman 
Instruments) for 45 seconds at 15,000 r.p.m. Protein was degraded by proteinase K 
(20 mg/ml) (Sigma) digestion at 55°C for 20 minutes. The RNA sample was bound 
to an RNeasy midi column and genomic DNA was degraded with DNase1 (20 µI) 
(Ambion) digestion at room temperature for 15 minutes. The RNA on the column 
was subsequently eluted using RNase-free water (50 µI). 
PolyA mRNA synthesis. PolyA mRNA was purified from total RNA with an 
Oligotex Mini Spin Column (Qiagen). Briefly, total RNA (50 µg) was mixed with 
Oligotex suspension buffer, washed, and eluted with buffer OEB. . 
Suppressive Subtractive Hybridization (SSH). Forward and reverse 
suppressive subtractive hybridization (PCR-select cDNA subtraction, Clontech) was 
completed according to the manufacturer's protocol using 1 µg mRNA as the starting · 
material. Double stranded cDNA was digested with Rsa1 and adaptors, which were 
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used for PCR amplification and sequence analysis, were ligated to the cDNA ends. 
An initial hybridization was completed by incubating tester and driver cDNA at 68°C 
to form hetero-hybrids of the tester and driver. A second hybridization was 
completed to further enrich for differentially expressed sequences. Differentially 
expressed cDNA was PCR amplified with PCR reaction buffer (1X), dNTPs (10 mM), 
PCR Primer 1 (10 mM), and Advantage cDNA polymerase mix (50X). The PCR 
conditions consisted of 94 °C for 5 minutes followed by 28 cycles of 94 °C for 30 
seconds, 66°C for 30 seconds, and 72°C for 1.5 minutes. A secondary PCR 
amplification was completed with PCR reaction buffer (1 X), Nested PCR primer 1 
(10 µM), Nested PCR primer 2R (10 µM), dNTPs (10 mM), and Advantage cDNA 
polymerase mix (50X). Secondary PCR conditions included 12or15 cycles of 94°C 
for 30 seconds, 68°C for 30 seconds, and 72°C for 1.5 minutes. The increase in 
PCR cycle number was completed to better visualize the amplified DNA. 
DNA Isolation. The final PCR products were subcloned into pT-Advantage 
(ClonTech) according to the manufacturer's protocol. Clones were initially grown on 
LB plates in the presence of ampicillin (50 mg/ml), were picked and plasmid DNA 
was isolated by alkaline lysis (protocol partially adapted from Marra et al. 1997). 
Briefly, bacteria are grown in terrific broth (1 ml) overnight at 37°C in the presence of 
ampicillin (50 mg/ml) in a 96 well format. Plasmid DNA was isolated with protocol 
adaptations, which included increasing Get/RNase solution to 100µ1 and 
resuspending the DNA pellets in 50 µI of 65° C water. cDNA inserts were excised by 
Eco RI restriction endonuclease digestion and size separated on a 1 % agarose gel. 
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Sequencing and Analysis. Fifty-eight plasmids, 31 from the forward 
subtraction and 27 from the reverse subtraction, which contained unique DNA insert 
sizes, were sequenced with an ABI 3700 sequence analyzer (Applied Biosystems 
Inc.; Iowa State University DNA sequencing facility). Clone identification was 
predicted by BLAST analysis. Gene identifications were given to clones that had 
;::go% homology to a known gene. Putative gene names were given to clones with 
>80% homology to a known gene. 
cDNA macroarray. In order to verify that all clones from the suppressive 
subtractive hybridization were sequenced, a macroarray was generated by spotting 
PCR amplified cDNA onto a nylon membrane. Isolated plasmid DNA from the 
suppressive subtractive hybridization served as the PCR template. Briefly, PCR 
buffer (1X), magnesium chloride (2.5 mM), dNTPs (20 nM}, T7 primer (10 mM), M13 
primer (10 mM), Taq polymerase (0.5 units), DMSO (1%), and the plasmid DNA 
were mixed for DNA amplification. The PCR program included two minutes at 95°C, 
30 cycles of 95°C for 30 seconds, 52°C for 30 seconds, and 72°C for 2 minutes, 
followed with a final extension at 72°C for 5 minutes. 
Amplified cDNA was manually spotted onto membranes (Biorad) using hand-
held multiprint equipment (V & P Scientific). Each clone was spotted in duplicate on 
the macroarray. The cDNA on the blot was denatured with 0.5 N NaOH/3M NaCl 
solution for 5 minutes, neutralized with 6X SSC solution for 5 minutes, and cross-
linked (120,000 µJoules) to the blot with a UV Stratalinker 2400 (Stratagene). 
Target Design and Hybridization. Radiolabelled target was generated by 
mixing PCR amplified subtracted cDNA from the 58 clones that had been sequenced 
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(50 ng/µ1), 10X Reaction buffer (1X), random primers (50 µM) (Ambion), a32P dCTP 
(15 µCi), and exo-Klenow Enzyme (0.5 unit). Radiolabeled probes were purified with 
Bio-spin columns (Biorad). Specific activity of radiolabeled probes was determined 
and equal amounts of probe (2.5 X 106 counts/ml) were hybridized in Quik-Hyb 
(Stratagene) at 65°C overnight. The blot was pre-hybridized for 1 hour at 65°C prior 
to the addition of radiolabeled probe. Blots were washed twice for 15 minutes with 
2X SSC/0.1 % SOS, followed by two 15-minute washes with 0.1 X SSC/0.1 % SOS. 
Subsequently, blots were exposed to film (Kodak) for 1 hour to visualize results. 
Macroarray Analysis for verification of differentially expressed cDNA. In order 
to validate the results of the SSH, macroarray analysis was performed on 31 genes 
that were potentially differentially expressed. The macroarray was generated as 
described previously. Radiolabeled target was generated from the original cDNA 
population used in the SSH analysis. The probe was made with DNA (50 ng), 
reaction buffer (1 x), random primers (50 µM) (Ambion), a32P dCTP (15 µCi), and 
exo-Klenow enzyme (0.5 unit). This mixture was incubated for 30 minutes at 37°C. 
Probes were purified with Bio-spin columns (Biorad). Specific activity of radiolabeled 
probes was determined and equal amounts of probe (2.5 X 106 counts/ml) were 
hybridized in Quik-Hyb (Stratagene) at 65°C overnight. Each blot was pre-
hybridized for 1 hour at 65°C prior to addition of radiolabeled probe. Blots were 
washed and visualized as described previously. For quantitative analysis, 
macroarray blots were exposed to a phosphoimaging screen for 1 hour and scanned 
on a phosphoimager (Molecular Dynamics). lmageQuant (Amersham) was used to 
determine signal intensity. 
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COMPASS and BLAST analysis of differentially expressed clones. 
Chromosomal location of the identified clones was predicted by COMPASS (Ma et 
al. 1998) analysis. This program compares sequence information from clones to 
human DNA sequences in the database. COMPASS has been shown to accurately 
predict chromosomal location and gene identification from bovine sequence through 
comparative mapping of cattle and humans (Rebeiz and Lewin 2000). BLAST was 
used to predict gene identification of the clone based on homology to previously 
sequenced genes. 
Radiation Hybrid Panel. Gene specific PCR primers (Table 1) for clones that 
were potentially located in regions with quantitative trait loci were used for radiation 
hybrid panel (Womack et al. 1997) and somatic cell hybrid panel (Womack and Moll 
1986) analysis. DNA {12.5 ng) was PCR amplified with 10X buffer (1X), Magnesium 
Chloride (2.5 mM), dNTPs (20 nM), gene specific primers (1 OmM), Taq polymerase 
(0.5 unit). The PCR program included 3 minutes at 92°C, 30 cycles of 92°C for 15 
seconds, gene dependant annealing temperature for 30 seconds {Table 2), and 
72°C for 30 seconds; and a final extension at 72°C for 10 minutes. PCR products 
were size separated on a 2% agarose gel. Each panel sample was scored as being 
positive, negative, or ambiguous. The PCR analysis was completed twice on all 
clones to confirm results, and ambiguously scored clones were repeated to clarify 
results. Statistical analysis of chromosomal location of the genes was completed in 
collaboration with Dr. James Womack and Dr. Srivinas Kata, Texas A & M 
University. Genes that were not assigned to a chromosomal location were mapped 
on the somatic cell hybrid panel. 
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Results 
Supressive subtractive hybridization. The visualized subtracted PCR 
products suggested that there were differentially expressed clones present as 
evidenced by the presence of several different PCR products (Figure 1). 
Furthermore, restriction endonuclease digestion of cDNA clones suggested that 
there were at least 58 uniquely sized cDNA inserts. 
DNA Sequence Homology. Sequencing was performed on plasmid DNA to 
determine clone identity. BLAST analysis suggested that there were 31 differently 
expressed genes based on the sequence of the clones. These were from both the 
forward and the reverse subtractions. Twelve clones appeared to have increased 
expression in the wild type embryo. Whereas, nineteen were suggested to have 
been expressed at a higher level in the double-muscled embryo. The other 27 
clones were the result of multiple fragments representing the same gene, further 
suggesting that these clones are differentially expressed. For example, HMGIC and 
ATPSJD had 3 and 2 sequenced fragments, respectively. 
Gene identification and chromosomal location was predicted for each clone 
with COMPASS (Ma et al. 1998). Comparative mapping suggested that HMGIC, 
MLL2, and ATPSJD were near the state the interacting QTL WBS14 QTL peak at 
-45 cM on STAS (Casas et al. 2000). 
SSH Verification. To further verify the results of the subtractive hybridization, 
macroarray analysis was completed. From quantitative analysis of the macroarrays, 
20 genes were found to have at least a 2-fold difference in expression levels in wild-
type and double-muscled embryos (Figures 1 & 2). Eleven clones appear to have 
38 
escaped subtraction, as their expression changed by< 2-fold. In the double-
muscled embryo, expression was increased in thirteen clones, while in the wild-type 
embryo, seven clones had increased expression (Figure 2 & Table 2). 
Radiation Hybrid Panel and Somatic Cell Hybrid Panel mapping results. 
MLL2, HMGIC, and ATPSJD were initially predicted to be in regions with QTL on 
Chromosomes S. From the radiation hybrid panel analysis, MLL2 and HMGIC were 
mapped to STAS. HMGIC was located centromeric to marker EST0373, and MLL2 
was positioned telomeric to U6311 O (Figure 3). In addition, MLL2 was mapped to 
STAS with the 12,000 rad radiation hybrid panel (Rexroad Ill et al. 2000; Dr. Eric 
Antoniou, University of Missouri, Columbia, personal communication). ATPSJD 
could not be placed to a single chromosomal location based on the radiation hybrid 
panel analysis {Table 3). However, with the use of the somatic cell hybrid panel 
(SCHP), ATPSJD was positioned on STAS with 94% confidence. Sall1 was mapped 
to STA18, near marker INRA 121 based on radiation hybrid panel results (Figure 4). 
Discussion 
In the present study, we identified genes that were differentially expressed 
due to the presence or absence of myostatin null alleles. From this research, 
myostatin appears to have downstream targets, as several genes have differential 
expression in double-muscled and normal-muscled animals. When comparing 
double-muscled and normal-muscled animals, there are differences in gene 
expression, protein synthesis, energy homeostasis, and cell number. The genes 
that were identified appeared to fall in the following general gene classes; 
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transcription factors, genes involved in protein synthesis and degradation, cell 
proliferation, or altered metabolism. 
Some of the genes identified were transcription factors, including dead box 
protein p72 (DDX17), high mobility group protein 1c (HMGIC), and Sall1. Sall1 is a 
spalt like gene. In drosophila, spalt has been shown to encode for a transcription 
factor, and has been found to be a downstream target of a TGF B superfamily 
member, decapentapalegic (de Celis et al. 1996). HMGIC has been suggested to 
be involved in fat cell proliferation, as HMGIC knockout mice have been shown to 
have a decrease number of adipose cells (Anand et al. 2000). In addition, the 
embryonic growth rate is decreased in HMGIC null mice resulting in a pigmy 
phenotype (Zhou et al. 1995). The changes in expression of these genes result in 
phenotypic changes that are similar to those seen in double-muscled and normal-
muscled animals. Thus, these transcription factors may be downstream targets of 
myostatin. 
Genes were also identified that are involved in protein synthesis and 
degradation. This included RPL 18, RPL3, RPL 11, and RPS3. Ribosomal protein 
L 18 has been shown to inhibit double stranded RNA protein kinase (PKR), which 
plays an important role in the regulation and inhibition of protein synthesis (Kumar et 
al. 1999, Koromilas et al. 1992). While ribosomal protein L3 expression is increased 
in mouse lines with higher fat deposition (Allan et al. 2000). As there is increased 
protein synthesis in the double muscled embryo, differences in the expression of 
these genes may be important in the observed differences in protein synthesis and 
degradation. 
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Genes including Raf, Thymosin beta-10 (TMSB10), and myeloid-lineage 
leukemia (MLL2) were also identified, which are involved in regulation of cell 
proliferation. In C2C12 cells, Raf protein has been shown to enhance the 
transcriptional activity of MyoD (Gredinger et al. 1998). Increased cell proliferation 
occurs in the double-muscled animal, and these genes may have an important role 
in this increase. 
There were also genes potentially involved in altering metabolism like 
transferrin, superoxide dismutase (SOD1), mitochondrial NOS, and ATPSJD. These 
genes may have an important role in energy homeostasis in the double-muscled and 
normal-muscled animals. This· may be important in energy use in the double-
muscled embryo, which has decreased fat deposition potentially due to increased 
energy consumption due to the increased lean mass present. 
The twenty-one genes that were differentially expressed in the suppressive 
subtractive hybridization and macroarray analysis are excellent candidate genes that 
may interact with myostatin. Some of these genes (MLL2, HMGIC and ATP5JD) 
were physically mapped within a region of a myostatin interacting QTL. However, an 
association study needs to be run to determine if these candidate gene do or do not 
interact with the presence or absence of myostatin. Interacting alleles that are 
identified may be downstream targets of myostatin. This information would increase 
the understanding of the molecular mechanisms whereby myostatin inhibits skeletal 
muscle growth. 
Despite the fact that SSH was successfully used to identify differentially 
expressed genes, which are candidate gene for interacting with myostatin, one must 
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be aware of potential limitation of suppressive subtractive hybridization analysis. 
First, ten genes appeared to escape subtraction as they had lower than 2-fold 
change in gene expression. Thus, the differential expression of all identified genes 
must be verified. Furthermore, the embryos used in this study were obtained from 
crossbred cattle. Thus, we cannot discount the possibility that differences in genetic 
background were responsible for the observed changes·in gene expression. 
Previous research has shown that genetic background can result in expression 
differences. For example, there are changes in fatty acid binding protein gene 
expression in pigs with different genotypes (Gerbens et al. 2001 ). 
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Table 1. Primer Information for genes mapped with Radiation Hybrid and Somatic Cell Hybrid Panel 
Annealing 
Gene Name Sense Primer Antisense Primer TemEerature ( OC) 
ATP5JD CCT CAC GGA GCC TAC CAT CA CAC GGG CCC TGA CTA CAN TT 59.4 
MLL2 GTA CAG AAG GCA AGC GAC AG CAG AGA GGT ACA TGC TGC AG 61. 8 I t 
HMGlC ACT TGC AAA GAC CTA CCT CCA AAC CAT CTC TCT TCC AGC CG 64.0 
SALLl CAC TTT TTC CGA GGA TGG GG CGC CGC AGC TGC TGA GAT AA 59.0 
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Table 2. Genes Identified by suppressive sub~ractive hybridization. 
a Gene name was determined by the closest human homologue. Identity had to be 
greater than 80% over a distance of > 60 base pairs. 
b The fold response is reported as wild-type expression divided by double-muscled expression. Results were 



















Table 2. Genes identified by suppression subtraction hybridization. 
Homology Homology 
Gene to Human Myostatin EST Gene to Human Myostatin 
Symbola cDNA Responseb Name Symbol a cDNA Responseb 
DDX17 82 0.667 WTES RAF 91 0.189 
SALL1 · 89 2.5 WTH10 RPL3 99 0.290 
SET 95 0 WTB8 EEF1A 98 0 
RAB2 90 1.36 WTF4 RPSS 87 0.518 
KIAA0697 85 22.8 WTA3 AFP 86 0.909 
ACTB 90 1.87 WTA4 Unique -- 0.236 
RPL18 83 14.17 WTAS RPL11 90 0.230 
TF 98 0.638 WTA6 TUBB 93 0.185 
Unique -- 2.43 WTA9 RPS9 94 1.46 
SOD1 90 2.0 WTA10 HBZ 98 0.260 
HB 88 3.5 WTB6 TUBGCP6 89 0.213 
NOS 87 1.64 WTD4 Unique -- 0.410 
TMSB10 98 2.44 WTF8 ProT-a 90 1.10 
MLL2 94 0.159 WTGS FETU 83 0.144 
ATPSJD 95 0.236 WTE11 RPS3 85 0.353 




Table 3. Radiation Hybrid Panel Mapping Results 
Predicted position of genes based on the 5000 rad radiation hybrid panel analysis 
(Womack et al. 1997). 
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Table 3. Radiation Hybrid Panel Mapping Results 
Gene Nearest 
Name Chromosome Marker LOO Theta Position 
MLL2 5 U63110 15.1 0.10 Below U63110 
HMG1C 5 EST0373 11.9 0.14 Above EST0373 
SALL1 18 INRA121 13.1 0.15 
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Figure 1. Final PCR amplification of suppression subtraction hybridization. 
Each visible PCR band is equivalent to a potentially differentially expressed cDNA. 
Lane 1 = 1 kb ONA ladder (Gibco). Lane 3 and 5 = 15 and 18 cycles, respectively, 
of double-muscled minus normal-muscled (i.e. gene expressed at a higher level in 
double muscle than in normal-muscled). Lanes 2 and 4 =15 and 18 cycles, 
respectively, of normal-muscled minus double-muscled (i.e. gene expressed at a 
higher level in normal-muscled than in double-muscled). 
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Figure 1 . Final Amplification of the Suppressive Subtractive Hybridization 
1 2 3 4 5 
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Figure 2. Macroarray analysis of gene expression of suppressive subtractive 
hybridization identified clones. 
Each of the genes listed in Table 1 are represented as two sequential spots. Gene 
order shown in Table 1 does not correspond to this figure. The corresponding spots 
on the two blots represent the same cDNA. The spot to spot coefficient of variation 
of signal intensity of a given cDNA clone is <5%. 
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Figure 3. Physical and linkage map of ATP5JD, MLL2, HMGIC, and associated 
markers 
BTA5 represents the cytogenetic map of bovine Chromosome 5. On the right hand 
side, radiation hybrid panel mapping results are shown, along with markers that 
were near each gene. MLL2, HMGIC, and ATPSJD are the genes of interest. 
* ATPSJD predicted based on human and bovine chromosome comparisons. 
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Figure 4. Physical and linkage map of SALL 1 and associated markers 
BTA 18 represents the cytogenetic map of bovine Chromosome 18. On the right 
hand side, radiation hybrid panel mapping results are shown, along with markers 
that were near each gene. Sall1 is the gene that was mapped. 
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Introduction 
Myostatin, a negative regulator of skeletal muscle growth, is a member of the 
TGF-(3 superfamily (Mc Pherron et al. 1997). Double-muscled breeds of cattle have 
20 to 30% more muscle mass as compared to normal-muscled commercial breeds 
of cattle (Swatland and Kieffer 1974). Researchers have shown that there are 
quantitative trait loci (QTL} that interact with myostatin (Casas et al. 1998, Casas et 
al. 1999, Casas et al. 2000, Casas eta/. 2001). Chromosome 5 has QTL for meat 
quality that interacts with the number of inactive myostatin alleles and the 
. ·background of the loci on chromosome 5 (Casas et al. 2000). 
Previously, we have identified a number of genes that are expressed in 
double-'muscled and wild-type bovine embryos. Three genes, MLL2, HMGIC, and 
ATP5JD, were located on BTA5. One gene, SALL 1, was mapped to BTA 18. 
Based on bioinformatic analysis, these genes were located in chromosomal regions 
with QTL for myostatin interacting alleles. Single nucleotide polymorphisms (SNPs) 
have been identified for three of these genes. These gene specific SNPs can be 
used to complete an association study to determine the gene by myostatin allele 
interaction. 
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Materials and Methods 
Identification of polymorphisms from clones identified in suppressive 
subtractive hybridization. Primers were designed (Vector NTI) from the sequence of 
clones identified in the suppressive subtractive hybridization for PCR analysis. 
Briefly, DNA (25 ng) was PCR amplified with 10X buffer (1X), magnesium chloride 
(2.5 mM), dNTPs (20 nM), gene specific primers (10mM; Table 1), and Taq 
polymerase (0.5 units). The PCR was completed on four crossbred sires that were 
used for the meat animal research genome scan experiment (Wheeler et al. 2001) 
citation. The PCR program included 3 minutes at 92°C, followed by 30 cycles of 
92°C for 15 seconds, gene dependant annealing temperature for 30 seconds (Table 
1 ), and 72°C for 30 seconds; and a final extension at 72°C for 1 O minutes. The PCR 
products were sequenced on a ABI 377 sequencer (Applied Biosystems), and 
sequences were aligned to identify single nucleotide polymorphisms (Vector NTI). 
BAG Clone Identification. The bovine RPCl42 BAC library (BACPAC 
Resources) was screened to identify BAC clones for ATP5JD, MLL2, HMGIC, and 
SALL 1. To screen the libraries, overgo probe hybridization was completed as 
previously described (Ross et al. 1999). Overgo oligos were generated from known 
bovine sequence for each gene utilizing an overgo primer design program, Overgo 
Maker (Washington University, St. Louis; 
http://www.genome.wustl.edu/tools/?overgo=1 ). Each oligo is 24 nucleotides long, 
and oligo pairs are 40-mers with 4 nucleotides overlap of the two oligos (Table 2). 
These oligos were utilized to generate probes to screen RPCl42 BAC libraries. 
Briefly, radiolabeled probes were generated as previously described (Ross et al. 
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1999), and subsequently purified with a Bio-spin column (Biorad). Specific activity of 
the radiolabeled probe was determined and equal amounts of probe (1 X 107 
counts/minute) were hybridized at 65°C overnight. Blots were pre-hybridized for 1 
hour at 65°C. Blots were washed twice for 15 minutes with wash 1 solution, followed 
by two 15-minute washes with wash 2 solution (Ross et al. 1999). Subsequently, 
blots were exposed to film for 1 hour to visualize results. 
Identification of Positive BAG clones. BAC clones stocks were streaked onto 
LB plates, which contained chloramphenicol (200 µg/ml). Bacteria from individual 
colonies were grown in terrific broth (4 ml) overnight and BAC DNA was isolated by 
alkaline lysis. Briefly, cells were pelleted by centrifugation at 14,000 rpm for 15 
minutes. The pellet was resuspended in a Tris-Cl pH 8.0 (50 mM)/EDTA (1 O 
µM)/RNase A (100 µg/ml) solution. Cells were lysed with NaOH (200 mM)/0.1 % 
SOS and neutralized with potassium acetate (3 M) pH 5.5. BAC DNA was 
precipitated and resuspended in 50 µI water. 
The isolated DNA was manually spotted onto a nylon nitrocellulose 
membrane (Biorad) using hand-held multiprint equipment (V & P Scientific). Each 
BAC clone was spotted in duplicate on the macroarray. The DNA on the blot was 
denatured with 0.5 N NaOH/3M NaCl solution for 5 minutes, neutralized with 6X 
SSC for 5 minutes, and cross-linked (120,000 µJoules) to the blot with a UV 
Stratalinker 2400 (Stratagene). 
Overgo probes were generated and hybridized to the macroarrays as 
previously described. Blots were exposed to film overnight to visualize results. 
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BAG Clone DNA Isolation for Sequencing. Plasmid DNA was isolated by 
alkaline lysis (Qiagen; protocol adapted in personal correspondence with Dr. Laura 
Marek). Briefly, starter culture (4 ml) was grown in terrific broth, which contained 
chloramphenicol (200 µg/ml) at 37°C for approximately 8 hours. Cells were 
harvested by centrifugation for 30 minutes at 3,000 r.p.m .. The cellular pellet was 
resuspended in buffer P1 (5 ml), and more P1 (5 ml) was added. Cell lysis was 
completed with buffer P2 ( 1 O ml) and the cellular solution was neutralized with 
buffer P3 (10 ml). Plasmid DNA was separated from cell lysates by centrifugation 
at 5,000 r.p.m. for 5 minutes and 13,200 r.p.m. for 30 minutes. Supernatant 
including plasmid DNA was centrifuged at 13,200 r.p.m. for another 30 minutes. The 
supernatant was applied to an equilibrated midi column (Qiagen), washed two times 
with buffer QC (1 O ml), and eluted with 65°C buffer QF (5 X 1 ml). DNA was 
precipitated with 100% isopropanol (13.5 ml) and the solution was incubated at 4°C 
overnight. Plasmid DNA was pelleted by centrifugation at 15000 r.p.m. for 30 
minutes, and resuspended in ddH20 (200 µI). 
BAG end sequencing and analysis. BAC end sequencing of BAC DNA was 
completed using universal primer T7 (5' AA T ACG ACT CAC TAT AG 3') with an ABI 
sequencer 377 (Applied Biosystems, Inc.) Sequence was analyzed to determine the 
quality of the sequence (Vector NTI). 
Identification of Polymorphisms. Primers, in regions with known bovine 
sequence, were designed to PCR amplify genomic DNA to in order to identify 
polymorphisms in the genes. PCR was completed with gene specific primers (Table 
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3) as previously described on DNA from four bulls representing families to complete 
an association study. 
Results and Discussion 
Polymorphisms in PGR amplified clone sequence. Sequence analysis of 
initial amplicons designed from SSH clones did not reveal any additional information. 
There was no variation in the haplotypes of the bulls. 
BAG library screening. The SAC filters were screened with probes for MLL2, 
HMGIC, SALL 1, and ATP5JD. SAC clones were identified for each gene (Table 4). 
At least 500 base pairs of SAC end sequence was obtained from each SAC end 
sequencing reaction, and this sequence was used to design additional primers for 
polymorphism detection. 
Identification of MLL2, HMGJG, SALL 1, and A TP5JD SNPs in bovine BAG 
end sequence. Based on the SAC end sequence, new primers were designed for 
polymorphism discovery. Comparison of the DNA sequence of the 4 bulls whose 
DNA was PCR amplified revealed 2 SNPs in HMGIC (Figure 1 ), 1 SNP in MLL2 
(Figure 2), and 3 SNPs in SALL 1 (Figure 3). All attempts to identify polymorphisms 
in ATP5JD have failed to date. 
In this study, single nucleotide polymorphisms that were identified will be 
used in future studies. This information will be used to map the genes by 




Casas, E., Keele, J. W., Fahrenkrug, S. C., Smith, T. P., Cundiff, L. V., and Stone, 
R. T. (1999) Quantitative analysis of birth, weaning, and yearling weights and 
calving difficulty in Piedmontese crossbreds segregating an inactive myostatin 
allele. Journal of Animal Science 77, 1686-92. 
Casas, E., Keele, J. W., Shackelford, S. D., Koohmaraie, M., Sonstegard, T. S., 
Smith, T. P., Kappes, S. M., and Stone, R. T.-(1998) Association of the 
muscle hypertrophy locus with carcass traits in beef cattle. Journal of Animal 
Science 76, 468-73. 
Casas, E., Shackelford, S. D., Keele, J. W., Stone, R. T., Kappes, S. M., and 
Koohmaraie, M. (2000) Quantitative trait loci affecting growth and carcass 
composition of cattle segregating alternate forms of myostatin. Journal of 
Animal Science 78, 560-9. 
Casas, E., Stone, R. T., Keele, J. W., Shackelford, S. D., Kappes, S. M., and 
Koohmaraie, M. (2001) A comprehensive search for quantitative trait loci 
affecting growth and carcass composition of cattle segregating alternative 
forms of the myostatin gene. Journal of Animal Science 79, 854-60. 
McPherron, A. C., Lawler, A. M., and Lee, S. J. (1997) Regulation of skeletal muscle 
mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90. 
Ross M.T. et al. (1999) Preparing and Hybridizing colony blots with overgo 
oligonucleotide probes. In: Current Protocols in Human Genetics (eds N.C. 
Dracopoli et al.) 5.6.18 - 5.6.24. Wiley. 
Swatland, H.J., and Kieffer, N. M. (1974) Fetal development of the double muscled 
condition in cattle. Journal of Animal Science 38, 752-7. 
Wheeler, T.L., Cundiff L.V., Shackelford S.D., Koohmaraie M. (2001) 
Characterization of biological types of cattle (Cycle V): carcass traits and 
longissimus palatability. Journal of Animal Science 79, 1209-22. 







GTA CAG AAG GCA AGC GAC AG 
ACT TGC AAA GAC CTA CCT CCA 
GGC CGC CAG TGT GAT GGA TA 
Antisense Primer 
Annealing 
Temperature ( °C) 
TGA TGG TAG GCT CCG TGA GG 
CGG CTG GAA GAG AGA TGG TT 











Table 3. BAC Primers 
Sense Primer 
AAT AGC AAG AGA GCA AAA GA 
CAT CTA AGC CAC CAC AGA AGC CC 
TTC CTC TCC AGA GGA TCT CT 
Antisense Primer 
TCA TTT AAC TAG AAA GCC TT 
GGG GTC CCA GNG AAT CAA AC 









Table 4. RPCl42 BAC Clones and corresponding 
gene name 








Figure 1. BAC Library Filter 
The spots in the four corners correspond to overgo controls that are used to 
determine filter orientation. Each BAC clone is represented by a unique set of 
duplicate spots, and positive signals identify BAC clones, which contain the gene of 
interest. 
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Figure 2. BAC Digestion 
BAC clones were digested with EcoRI restriction endonuclease. 
Lane 1: ;t Ladder (250 ng) (lnvitrogen) 
Lane 2: BAC Clone 5, which contains SALL 1 
Lane 3: BAC Clone 124, which contains ATP5JD 
Lane 4: BAC Clone 227, which contains HMGIC 
Lane 5: BAC Clone 230, which contains MLL2 
Lane 6: 1 kb ladder (lnvitrogen) 
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Figure 2. BAC Digest 
1 2 3 4 5 6 
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Figure 3. MLL2 
a. MLL2 is illustrated as a single line with blocks showing the position of exons 
near the region where sequencing has been completed. Short lines parallel 
to the gene identify the regions of the gene that has been sequenced. 
Sequence has been obtained from the T7 end of the BAG clone, as well as 
exons 45 and 46, and the intervening intron. The orientation of T7 relative to 
the exons has not been determined, but is simply illustrated to show regions 
that are sequenced. Exon 45 and 46 were predicted based on human MLL2 
sequence. The * identifies the region in which a single nucleotide 
polymorphism has been identified. 
b. Sequence shown corresponds to bovine genomic DNA equivalent to BAG end 
sequence. The single nucleotide polymorphism is identified with a GIA 
substitution at nucleotide position 416. 
c. Partial sequence and chromatograms near the region of the single nucleotide 
polymorphisms are shown. 
I. Partial sequence and chromatogram are given with the G/A single 
nucleotide polymorphism at nucleotide 416 highlighted. 
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Figure 3. MLL2 
A. MLL2 
'U Exon 45 46 \'l :::· .. ·.·.·.---\-, .................. ~~ ............... ,~\~--------
B. 
C. 
1 attagcaaga gagcaaaaga gaaaaaagag 
. . . . . . . .. . . . . . . . . . . . . . .. . . . . .. . . . 
61 acccaaagtc tttttccaat ctaatctcag 
. .. . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. 
121 tgttaggagt gactcacta g gtccagccta 
.. . .. .. .. . . . . . .. .. . .. . . . . .. . . .. .. .. .. . . . .. .. 
181 tgactcctag aaagaggggt acaatgggga . .. . . . .. .. . . . . ........ .. ..... . . .. .. . . . . .. . 
241 gcagttctaa aaactctatc t ctatattta 
. . .. . . . . . . . . . . . . . . . . . .. .. . . . . .. . . . 
301 aggatctgac tggaccagtt tgggttagga 
.. . . . . . . . .. .. . .. . . . . . .. .. . . ...... .. . . .. 
361 gatgggacaa gatcatgtaa taaattttat 
.. . . .. .. . .. . . . .. . . . . . .. . .. . . . . . . . . . . . 
421 tgttaaaggc tttc 
............ 
A A T A G G A A A 
A A T A G A 
G 
A A A 
agagcgagca aaaagagccc tcaaagtaaa 
.. .. .. .. .. . .. . . . . . . . . . . . . . . .. .... ... ... 
aaacaacacc ttattacttt tgctgcagtc 
. .. . .... ... . . . . . . . . .. . . .. ....... .... 
tagtcaaggg gaaaacatta cataa g a ata 
. .. .. . .. . . .. . . . .. ... .... . ... .. . ..... ... .. . .... 
acccacctta gaagctgtgt attata tt a t . . . . . . . .. . .. . . . . . . .. . . . . .. .. ..... 
attgtcacag atgtcaaatt tct gataggg 
........ . .. . . . . . ... . . . . . . . . .. . .. . . 
tttctcc tgt gggtcagtta gccttggcta 
. . . . . . . . .. . . . . . . . .. .. . . . ..... ...... . 
tattgttaga tatttctaga gaataggaaa 
. . . . . . . . . . . ....... ... ..... a .. . . 
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Figure 4. HMGIC 
a. HMGIC is illustrated as a single line with blocks showing the position of exons 
near the region where sequencing has been completed. Short lines parallel 
to the gene identifies the regions of the gene that has been sequenced. 
Sequence has been obtained from the T7 end of the SAC clone, as well as 
from exon 5 and the previous intron. The orientation of T7 relative to the 
exons has not been determined, but is simply predicted to show regions that 
are sequenced. Exon 5 was predicted based on human HMGIC sequence. 
The * identifies the region in which two single nucleotide polymorphisms have 
been identified. 
b. Sequence shown corresponds to bovine genomic DNA equivalent to BAC end 
sequence. The single nucleotide polymorphisms are identified, with a TIC 
substitution at nucleotide position 211 and a A/G substitution at nucleotide 
position 492. 
c. Partial sequence and chromatograms near the region of the single nucleotide 
polymorphisms are shown. 
I. Partial sequence and chromatogram are given with the TIC single 
nucleotide polymorphism at nucleotide 211 highlighted. 
II. Partial sequence and chromatogram are given with the A/G single 
nucleotide polymorphism at nucleotide 492 highlighted. 
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Figure 4. HMGIC 
A. HMGIC 
\\ Exon --*-· \\ ... I___ ..... 
4 5 
13. 1 catctaagcc accacagaag cccccctttt ccctgagagt ccgtctaaag acataaattc 
61 gttatctttt caaagaatca actcttagtt tcactgaatc tttcctattg ttctttggtt 
121 tctgtttcct ttatttccac tttggtattt attattttct tccttcaact aacgggggct 
181 ttgttctttt tcacactttt aggtgtgaag t tagattttt ttaatt tgaa atctttcttc 
. . ....... . .... •. .... . .... ... .. c ............................ . 
241 tttctggagg taggcctgga ctgttatgga cttccctctt agaactgctt ttgcaacgtt 
301 attttggcta ttccaggtcc tttgcattcc cacatgaatt ttaaaatcag cttgtcaatt 
361 ttataagaca aaagcctact ggattttgac tggagttgct ttaaatctag atctatagat 
421 ccaattagaa aagaatattg agacttctga cccaggagca tggtgcacct ctctatttac 
481 atagaacttt c acatttctt tacagaacac ttggtagttt tcagtgtaca gaagaccact 
.. .. .. . ... . g .. ....... . .. ...... . . ... .. . .............. . . . .... . 
541 gaccagtgta gtcactcact tgtgtttgat tcccc 
C. 
I. G A A G T T A G II. T T T C A C A T 
G A A G C T A G 
T 




Figure 5. SALL 1 
a. SALL 1 is illustrated as a single line with blocks showing the position of exons 
near the region where sequencing has been completed. Short lines parallel 
to the gene identifies the regions of the gene that has been sequenced. 
Sequence has been obtained from the T7 end of the BAG clone, as well as a 
short region contained within exon 2. The orientation of T7 relative to the 
exons nas not been determined, but is simply predicted to show regions that 
are sequenced. Exon 2 was predicted based on human SALL 1 sequence. 
The * identifies the region in which two single nucleotide polymorphisms have 
been identified. 
b. Sequence shown corresponds to bovine genomic DNA equivalent to BAG end 
sequence. Three single nucleotide polymorphisms were identified, with a GIG 
substitution at nucleotide 26, an A/G substitution at nucleotide 57, and a GIA 
substitution at position 250. 
c. Partial sequence and chromatograms near the region of the single nucleotide 
polymorphisms are shown. 
I. Partial sequence and chromatogram are given with the GIG single 
nucleotide polymorphism at nucleotide 26 highlighted. 
II. Partial sequence and chromatogram are given with the A/G single 
nucleotide polymorphism at nucleotide 57 highlighted. 
Ill. Partial sequence and chromatogram are given with the GIA single 
nucleotide polymorphism at nucleotide 250 highlighted. 
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Figure 5. SALL 1 
A. SALL1 
B. 1 catctaagcc accacagaag cccccctttt . . .. .. .. .. . .. . .. . . . . . . . .. . . ..... g .. . . 
61 ttcgtttatc ttttcaaaga atcaactctt 
........... .. . . . . . . . .. . .. ..... . ... . . 
121 gtttctgttt cctttatttc cactttggta 
. . .. .. .. . .. .. . .. .. .. .. .. .. .. .. . .. .. ............ ... 
181 ggctttgttc tttttcacac ttttaggtgt . . .. . .. . . .. .. . ..... .. ......... .. .. . . .. .. .. . .. .. 
241 cttctttctg gaggtaggcc tggactgtta 
. .. .... . . a ................ .. . .. .. . . .. . . .. 
301 cgttattttg gctattccag gtcctttgca 
. . . .. . . . . .. . .. . . .. .. . .. .. .. . .. . .... . ..... 
361 aattttataa gacaaaagcc tactggattt 
. . . . .. .. .. . .. . . .. .. .. .. .. . .. . .. .. .. .. .. .. .. . .. . . 
421 agatccaatt agaaaagaat attgagac . . .. .. . . . . . . . . .. . .. . .. .. .. . . . .. . .. .. . .. 
C. 
I.CCC CC C TTT 
CCC CC G TTT 
c 
tccctgatga gtccgtctaa agacataaaa . .. .. .. . . . . . . . ................ . ... . . c ... 
agtttcactg atctttccta ttgttctttc . ............ . .. . .. . .. . .. .. . .. .. .. . . . . .. .. 
tttattattt tcttccttca actaacggtg 
. .... . ....... . ..... ..... .... . .. . . . . . .. .. .. 
gaagttagat ttttttaatt tgaaatcttt 
. . . .. . . . . . .. . ..... . ... . .. . . .. .. .. .. .. . . 
tggacttccc tcttagaact gcttttgcaa 
.. . . . . . .. .. .. .. . ............ . ................ 
ttcccacatg aattttaaaa tcagcttgtc 
. .......... . .. .. . . . . .. .. . .. . .. . . . . . . . 
tgactggagt tgctttaaa t ctagatctat . .. . . . .. .. . . .. .. . .. . . .. .. . .. . ....... ...... 
II. A C A T A A A A T 
ACAT C AAAT 
A 
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Figure 3. Continued 
lltCTTT G GTT 
CTTT A GTT 
G 
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Chapter 4: Macroarray Analysis of Gene Expression 
of Several Genes in Myoblasts and Myotubes 
Jackie Potts, David Henderson, and James Reecy 
Iowa State University, Department of Animal Science, 2255 Kildee Hall 
Ames, IA 50011 
Introduction 
The objective of this study was two fold. The first was to determine if the 
genes that were identified by suppressive subtractive hybridization (SSH) were 
expressed in proliferating satellite cells or myotubes. Due to the fact that the SSH. 
was completed using the whole embryo, it was not known if they were expressed in 
skeletal muscle. The second objective was to determine if genes that were found to 
be expressed in muscle from the first objective are differentially expressed in 
proliferating bovine satellite cells and the terminally differentiated myotubes. In this 
study, gene expression levels were determined in myoblasts and myotubes by 
macroarray analysis. Arrays were made using DNA from the genes identified by the 
SSH, as well as genes known to be expressed in skeletal muscle. The probe was 
prepared using RNA isolated from bovine satellite cells that were collected at 0, 24, 
48, and 72 hours after the addition of differentiation media. In addition, genes were 
analyzed to determine whether there was a significant change in expression of that 
gene at the four time points. 
Materials and Methods 
DNA amplification for Macroarray Analysis. In order to amplify the cDNA to 
use for the macroarray production, PCR was completed with plasmids from the SSH 
79 
and skeletal muscle libraries. For the PCR, plasmid DNA, forward (5' AGG AAA 
CAG CTA TGA CCA T 3') and reverse (5' GTT TIC CCA GTC ACG ACG 3') 
primers (.5 µM), dNTPs (.2 nM), Taq (2.5 U), buffer (1X), DMSO (1%), magnesium 
chloride (2.5mM), and water (to 100 µI) were mixed. The PCR program included 
95°C for two minutes, 30 cycles of 95°C for 30 seconds, 52°C for 30 seconds, and 
72°C for 2. minutes, followed with a final extension at 72°C for 5 minutes. 
Spotting DNA onto nylon membranes. Multiprint equipment (V & P Scientific) 
was used to manually spot the DNA (approximately 250 ng) onto a nylon 
nitrocellulose membrane (Biorad). Each gene was spotted in duplicate on the array. 
The DNA on the membrane was denatured by placing the blot in a 0.5N NaOH/3M 
NaCl solution for 5 minutes, and subsequently was neutralized in a 6X SSC solution 
for 5 minutes. Finally, the DNA was cross-linked (120,000 uJoules) to the blot with 
the UV Stratalinker 2400 (Stratagene). 
Cell Culture on Bovine Satellite Cells. Cell culture was completed as 
described by (Johnson et al. 1998). Briefly, satellite cells were plated onto 35 mm 
plates (Fisher) coated with reduced growth factor basement membrane Matrigel 
(Becton Dickinson Labware). Plating media consisted of Dulbecco's Modified Eagle 
Medium (DMEM) and 10% fetal bovine serum (FBS). Cells were allowed to 
proliferate for 48 hours. Then, differentiation media was added, which consisted of 
DMEM, 3% horse serum and 1.5 µg BSA-linoleic acid/ml. The cells were incubated 
at 37°C with 95% humidity and 5% C02• 
Bovine Satellite Cell RNA Isolation. Cells were collected using Trizol 
(lnvitrogen) according to the manufacturer's protocol. Briefly, Trizol reagent (3 ml) 
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was added to lyse cells in the culture dish. Chloroform (600 µI) was added to the 
cell lysates. After mixing, RNA was isolated in the top aqueous layer by 
centrifugation at 12,000 X g for 10 minutes at 4°C. The RNA was precipitated with 
isopropanol, and the RNA pellet was resuspended in RNase free water. 
mRNA Amplification. In order to have sufficient RNA for the number of 
probes, the RNA was amplified with the message amp aRNA kit (Ambion) according 
to manufacurer's protocol. Briefly, first strand cDNA synthesis was completed from 
total RNA (1 µg): Then, second strand synthesis and cDNA purification was 
completed with the cDNA filter cartrige. In order to make aRNA, in vitro transcription 
was completed and then the aRNA was purified with the aRNA filter catridge. The 
aRNA was resuspended in nuclease free water. 
Probe design for macroarrays. The probe was made according to 
manufacturer's protocol with adaptations (Superscript II RNase H- Reverse 
Transcriptase, lnvitrogen). To make the probe, aRNA (1.5 µg), random primers (50 
µM) (Ambion), and water (to 48 µI) were mixed, heated to 75°C for 1 O minutes, and 
placed on ice for 5 minutes. Subsequently, buffer (5X), dTT (.1 M), Rnase inhibitor (1 
µI) (Ambion), dNTP-dCTP (10mM), and a32P dCTP were added, warmed to 42°C for 
2 minutes, and Superscript II (400 Units) (lnvitrogen) was added. The solution was 
mixed gently and incubated at 42°C for 1 hour. To degrade RNA that was still 
present, the probe was boiled for 5 minutes and placed on ice. Sodium hydroxide 
was added and the solution was heated for 15 minutes at 37°C. Then, Tris HCI and 
HCI (5M) was added. Following this, the probe was mixed with church buffer (Ross 
81 
et al. 1999) (1 ml) and hybridized to the blot. The blot was prehybridized for 1 hour 
in church buffer (50 ml) prior to hybridization. 
Hybridization and washing. The blot was hybridized overnight at 65°C in 
church buffer. The following day, the blot was washed twice for 15 minutes with 2X 
SSC/0.1 % SOS; followed by two washes for 15 minutes with 0.1 X SSC/0.1 % SOS . 
. Visualization. After washing, the blot was exposed to a phosphorimaging 
screen for 48 hours and scanned on a phosphoimager (Molecular Dynamics). The 
blots were also exposed to film for 48 hours to visualize. lmageQuant (Amersham) 
was used to determine the intensity of each of the spots so that a statistical analysis 
could be completed. 
Statistical Analysis of the arrays. A linear model was used to determine 
whether the genes were expressed at any of the four time points. Fixed effects were 
background intensities and signal intensities. The signal and background intensities 
were LOG transformed so that they were normally distributed. These intensities 
were used as the Y variable. Model effects included a random plate effect and 
random blot effect. Each treatment for each gene was individually analyzed. 
In order to determine whether genes were differentially expressed between 
the four time points, another model was analyzed. Data were inspected for trends 
between median background signal and median signal intensities using a dot plot of 
the data. A significant trend was identified and removed using a linear model 
predicting background intensities from the corresponding signal intensities for each 
blot individually. Residual values from each regression were relocated ·such that the 
minimum intensity value for each blot was set to zero and the collection of residuals 
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used as the dependent values in a mixed linear model. Analysis of the macroarray 
data consisted of a mixed linear model with fixed effects of treatment k and gene I 
with random effects of plate I and blot j within plate i. Yiikl was a residual from the 
individual blot analyses and epsiloniikl the error term for the model: Yiikl = mu + platei + 
blot(plate)ij + treatmentk + gene1 +(treatment* gene)1<1 + epsiloniikl· Inspection of a 
QQ plot of the residuals from this model revealed heavy tailed t statistics that did not 
match standard distributions. Bootstrapping (Efron and Tibshirani, 1993) was then 
employed to empirically determine the distribution of the t statistic from the data. A 
total of 2,000 bootstrap samples were obtained using the residuals from the mixed 
linear model as signal intensities under the null hypothesis of no difference between 
treatments. Frequentist p-values were obtained from the empirical distribution of t 
statistics and adjusted for the 864 tests using the false discovery rate (FDR, 
Benjamini and Yekutieli, 2001) method. The interpretation of the FDR is that when 
controlling the test at the alpha level, we expect alpha percent of the "significant" 
alternative hypotheses to be false. 
Results and Discussion 
From the 31 clones that were spotted on the macroarray, seven genes were 
found to be expressed at a minimum of one time point (Table 1, Table 2). Only one 
of these seven genes, gamma tubulin complex (TUBGCP6) had differential 
expression in myoblasts and myotubes. 
From the 7 genes that are expressed, (3-actin was the only gene expressed at 
all four time-points. Previous research has shown that (3-actin is expressed in fetal 
' . 
and adult skeletal muscle (Reviewed by Khaitlina 2001 ). Two genes, SET and 
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TUBGCP, were first expressed 24 hours after the addition of differentiation media, 
which is when myoblasts began to fuse to form myotubes, and were expressed 
throughout differentiation. ND5, a mitochondrial gene, and ATPSJD, which is an 
ATP synthase, were only expressed when the majority of myoblasts had 
differentiated into myotubes, which was at 48 and 72 hours after the addition of 
differentiation media. Finally, ribosomal protein (RPL 18) and elongation factor 1 A 
(EEF1 A) was only expressed at the final time point, 72 hours after the addition of 
differentiation media. 
From the seven genes that were expressed in myoblasts or myotubes, only 
three of them were differentially expressed in double-muscled and normal-muscled 
animals. These included ATPSJD, RPL 18, and TUBGCP6. 
The only gene shown to have differential expression between myoblasts and 
myotubes was TUBGCP. This protein had significantly higher expression in 
myotubes, as compared to myoblasts. A control gene, cardiac alpha actin, was 
expressed only in differentiated myotubes. Previous research has shown that 
cardiac a-actin is expressed in skeletal muscle during fetal development and in cell 
culture (Reviewed by Khaitlina 2001 ). 
From this research, we obtained new information about the expression 
pattern of several genes in skeletal muscle. In this experiment, only a small number 
of genes from the SSH were shown to be expressed in the myoblasts or myotubes. 
The genes that were not expressed in myoblasts or myotubes, may have been 
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Table 1. Genes whose expression was not detected in 
myoblasts and myotubes. f 
Gene Name Gene Name Gene Name 
HMGIC aFP RAF 
MLL2 TMSj310 TUBj3 
KIAA 0018 Pro-Ta SOD 
KIAA0687 RAB2 TF 
DDX17 SALL1 HBZ 
UNIQUE DMB9 UNIQUEWTA4 HB 
RPS3 RPL3 FETU 
RPS9 RPL11 RPS5 
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Table 2. Genes Expressed in Myoblasts and Myotubes 
*Genes tend to be expressed. 
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T~ble 2. Genes that are expressed in myoblasts and/or 
myotubes at TO, T24, T 48, and/or T72 
3ENE NAME TIME p GENE NAME TIME p 
POINT VALUE POINT VALUE 
ATP5JD T48 0.0829* TUBGCP6 T24 0.0924* 
ATP5JD T72 0.0075 TUBGCP6 T48 0.0088 
ND5 T48 0.0239 TUBGCP6 T72 < 0.0001 
ND5 T72 0.0875* EEF1A T72 0.0029 
(3-ACTIN TO 0.0173 RPL18 T72 0.0105 
(3-ACTIN T24 0.0049 SET T24 0.0560* 
(3-ACTIN T48 0.0008 SET T48 0.0554* 
(3-ACTIN T72 < 0.0001 SET T72 0.0367 
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Figure 1. Gamma Tubulin Complex (TUBGCP6) 
Expression levels of the gene are given as least squared means from the statistical 
analysis. Time points correspond to 0, 24, 48, and 72 hours after the addition of 
differentiation media. Expression levels indicated are significant with a false 
discovery rate of 5%. 
a,b least squared means with different superscripts across time points differ (p < 
0.05) 
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Figure 1. TUBGSP6 Expression 
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Figure 2. Cardiac a-Actin Expression 
Expression levels of the gene are given as least squared means from the statistical 
analysis. Time points correspond to 0, 24, 48, and 72 hours after the addition of 
differentiation media. Expression levels indicated are significant with a false 
discovery rate of 5%. 
a,b,c,d least squared means with different superscripts across time points differ (p < 
0.05) 
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Figure 2. Cardiac a-Actin Expression 
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Chapter 5: General Conclusions 
Muscle mass is determined by a number of factors. However, this study 
focused on one gene, myostatin, whose primary function is to negatively regulate 
skeletal muscle mass. The results of this study suggest that there are genes whose 
expression changes in the presence or absence of myostatin. Twenty-one clones 
were identified that were differentially expressed in double-muscled and normal-
muscled bovine embryos during early embryonic development, specifically just after 
myostatin is first expressed in the somite. 
Radiation hybrid panel and somatic cell hybrid panel mapping were utilized to 
determine the location of 4 of the genes that were identified. MLL2 and HMGIC 
were mapped to locations on Chromosome 5 that were consistent with predictions 
from comparative mapping between human and bovine. ATP5JD was mapped to 
Chromosome 5 with 94 % confidence using the somatic cell hybrid panel. This was 
also in agreement with the position of ATP5JD from human and bovine 
comparisons. These three genes were mapped or predicted to be near quantitative 
trait loci for retail product yield grade, fat depth, and Warner Bratzler shear force at 
day 14 postmortem. Finally, SALL 1 was mapped to a position on chromosome 18 
that was consistent with the placement of SALL 1 on human chromosome 16. 
Therefore, further analysis was completed to identify single nucleotide 
polymorphisms, which will be utilized to complete an association study to identify if 
these are myostatin interacting alleles. In addition, these genes may contain the 
alleles responsible for the quantitative trait loci that have been identified. 
Future research will include a microarray analysis of differential expression 
myostatin null and wild-type mice. This will be completed as another confirmation 
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that genes are differentially expressed in the presence or absence of myostatin. 
Expression differences will be determined at two time points prenatally, one at 13.5 
d.p.c. after myostatin is first expressed and another at 17.5 d.p.c., which is after 
secondary myotube formation begins. From this analysis, more genes may be 
identified that are differentially expressed. These, in turn, could be tested for 
differential expression in double-muscled and normal-muscled cattle. New genes 
identified would be additional candidate genes for myostatin interacting alleles. 
With the use of a skeletal muscle specific bovine microarray, expression 
differences in skeletal muscle from double-muscled and normal-muscled could be 
analyzed at other time points in skeletal muscle development, beyond that 
completed with the suppressive subtractive hybridization. 
Further research can be completed on unique clones to determine what gene 
they are or to identify their biological function. These genes may have an important 
role in skeletal muscle development. As they were identified as being differentially 
expressed in the double-muscled and normal-muscled embryos, these genes may 
be a missing link in understanding the molecular mechanisms whereby myostatin 
negatively regulates skeletal muscle mass. 
Results from this study can be used to further characterize the molecular 
mechanism of myostatin. A number of genes were identified to be differentially 
expressed, and these may be involved in myostatin activated pathways. 
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